Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR6K2 Activators

The chemical class of OR6K2 activators encompasses a diverse array of compounds that share the common characteristic of being able to upregulate the signaling pathways associated with the OR6K2 olfactory receptor. These activators operate primarily by modulating the intracellular concentrations of second messengers like cyclic adenosine monophosphate (cAMP), which play a pivotal role in the signal transduction mechanism of olfactory receptors. The engagement of these activators with the signaling pathway does not hinge on direct interaction with the OR6K2 receptor itself, but rather on the elevation of cAMP levels that can amplify the receptor's response to its specific ligands.

Within this class, activators can function through various mechanisms, such as the direct activation of adenylate cyclase to boost cAMP synthesis, the inhibition of phosphodiesterase enzymes to prevent cAMP breakdown, or the activation of other G protein-coupled receptors that converge on the same signaling cascades influenced by OR6K2. By elevating cAMP, these activators facilitate the activation of protein kinase A (PKA), which then phosphorylates various proteins within the olfactory sensory neuron, leading to a response that culminates in the perception of smell. This cascade of events underscores the importance of cAMP modulators in the function of olfactory receptors and highlights their role in the amplification of the sensory signal initiated by OR6K2.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin directly activates adenylate cyclase, increasing cAMP levels which could possibly activate OR6K2 after odorant binding.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

IBMX inhibits phosphodiesterases, increasing intracellular cAMP by preventing its breakdown, which could possibly activate OR6K2.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
5 g
100 g
250 g
1 kg
5 kg
$32.00
$66.00
$95.00
$188.00
$760.00
13
(1)

Caffeine acts as a competitive inhibitor of phosphodiesterases, leading to increased cAMP levels that could possibly activate OR6K2.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$75.00
$212.00
18
(1)

Rolipram selectively inhibits phosphodiesterase 4, leading to increased cAMP levels in cells, which could possibly activate OR6K2.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$103.00
$245.00
8
(2)

Zaprinast is another phosphodiesterase inhibitor that increases cAMP, and could possibly activate OR6K2.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$31.00
$83.00
6
(0)

Theophylline is a phosphodiesterase inhibitor; by increasing cAMP, it could possibly boost OR6K2 activity.

Vardenafil

224785-90-4sc-362054
sc-362054A
sc-362054B
100 mg
1 g
50 g
$516.00
$720.00
$16326.00
7
(1)

Vardenafil is a selective inhibitor of cGMP-specific phosphodiesterase type 5 (PDE5)

Tadalafil

171596-29-5sc-208412
50 mg
$176.00
13
(2)

Tadalafil, another phosphodiesterase 5 inhibitor, might enhance OR6K2 activity by increasing cAMP levels.

Terbutaline Hemisulfate

23031-32-5sc-204911
sc-204911A
1 g
5 g
$90.00
$371.00
2
(0)

Terbutaline is a beta-2 adrenergic agonist that can increase cAMP, which could possibly affect the signaling of OR6K2.